Search - tctmd.com

Displaying 141 - 160 of 228

Sort: Relevancy | Date

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

Presentation ECHO 2018

Echocardiographic Approach To Congenital Heart Disease: The Postoperative Adult

Presenter: Karen Stout

April 20, 2018

Presentation ECHO 2018

Evaluation of Pregnant Patients with Heart Disease

Presenter: Karen Stout

April 20, 2018

Presentation ECHO 2018

Clinical Decision Making in Patients with Endocarditis: The Role of Echocardiography

Presenter: Jennifer E. Liu

April 20, 2018

Presentation ECHO 2018

Pulmonary Hypertension and the Role of Echocardiography

Presenter: Linda D. Gillam

April 19, 2018

Presentation ECHO 2018

Clinical Applications of Contrast (Ultrasound Enhancing Agents) 2018

Presenter: Linda D. Gillam

April 18, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Daily News

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Caitlin E. Cox

September 06, 2017

Advertisement

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Echocardiographic Approach To Congenital Heart Disease: The Postoperative Adult

Evaluation of Pregnant Patients with Heart Disease

Clinical Decision Making in Patients with Endocarditis: The Role of Echocardiography

Pulmonary Hypertension and the Role of Echocardiography

Clinical Applications of Contrast (Ultrasound Enhancing Agents) 2018

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content